Nitazene was first developed in the 1950s as an analgesic, but was never approved for medical use. Instead, it was “limited ...

A class of synthetic drugs called nitazines have been around since the 1950s - but are quickly gaining a foothold in street ...

The group of researchers were the first to take snapshots of the moment naloxone reverses an opioid overdose in the brain.

Scientists have visualized for the first time how opioids such as loperamide and the antidote naloxone engage a key brain receptor, offering insight that could lead to better pain treatments.

The escalating opioid crisis, especially in the Appalachian region, is a stark reminder of the harsh realities of addiction. A recently published study by the Rothman Orthopaedic Institute Foundation ...

The Food and Drug Administration’s latest plan to study whether opioids are effective as a chronic pain treatment is facing significant resistance from addiction and pain care experts. A planned ...

The Interactive Talk presentation, “Opioids’ Impact on Pain-Interference and Sleep: The OARS Pilot Study”, will take place on Friday, June 24 th, 2022 at 8 p.m ...

Researchers have identified a new way to make opioids safer, increasing the pain-relieving properties of opioids while decreasing unwanted side effects through the spinal inhibition of a Heat shock ...

A new study sheds light on an understudied aspect of today's opioid crisis: What happens to the cardiovascular health of babies exposed to opioids in the womb. The outcomes of the study suggest that ...

Dr. Mellar Davis discusses the joint guideline from MASCC, ASCO, AAHPM, HPNA, and NICSO on opioid conversion in adults with cancer. He reviews the limited evidence, and the formal consensus process ...